Skip to main navigation Skip to search Skip to main content

Safety and efficacy of ombitasvir, paritaprevir and ritonavir with ribavirin (RBV) in chronic HCV genotype 4: systematic review and meta-analysis

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish (US)
Title of host publicationHepatology International
StatePublished - Feb 2017

Cite this